Archived – Updated Safety Information Announced In Canada For Patients Taking Topamax (topiramate) Regarding Higher Than Normal Blood Acid Levels – Janssen-ortho Inc. – For The Public

TOPAMAX (Topiramate) Safety Update Janssen-Ortho Inc. announced updated safety information in Canada for patients taking TOPAMAX (topiramate) regarding the risk of higher than normal blood acid levels. This applies to patients across Canada who are currently using this medication. The announcement was made to inform patients and healthcare providers of this safety concern associated with the drug.

Reason

New safety information

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2004-01-26

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/d1471e9c-4d76-42d5-9f90-d6e447aeb29d